.After antibody-drug conjugate (ADC) specialist Seagen was sold to Pfizer in 2013 for a whopping $43...
.On the heels of a phase 3 succeed that neglected to thrill capitalists, Ironwood Pharmaceuticals is...
.Do not quit Monte Rosa Rehabs right now. The Boston-based biotech is actually enjoying after signin...
.Accept to today's Chutes & Ladders, our summary of notable management hirings, shootings as well...
.Commemorating his provider's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer soun...
.AbbVie has actually come back to the source of its own antipsychotic goliath Vraylar trying to find...
.GenSight Biologics is full weeks out of running out of money. Again. The biotech only possesses eno...
.Monopar Therapies is actually recuperating a medicine coming from the dump of AstraZeneca's uncommo...
.With brand new data out on Arcus Biosciences' experimental HIF-2a inhibitor, one team of analysts w...
.After forming a genetics treatment relationship along with Dyno Therapeutics in 2020, Roche is actu...